Date published: 2025-9-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sulfacetamide sodium salt (CAS 6209-17-2)

0.0(0)
Write a reviewAsk a question

Application:
Sulfacetamide sodium salt is a sulfonamide antibiotic
CAS Number:
6209-17-2
Molecular Weight:
236.22
Molecular Formula:
C8H9N2O3SNa
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Sulfacetamide sodium salt, identified by the CAS number 6209-17-2, is a sodium salt form of sulfacetamide, a sulfonamide compound. It functions by inhibiting the bacterial enzyme dihydropteroate synthase, which is crucial in the synthesis of folic acid, a vital component for bacterial growth and replication. By blocking this enzyme, sulfacetamide sodium salt impedes the production of dihydrofolic acid, thus preventing bacterial cells from synthesizing their own folic acid, which is essential for their proliferation and survival. This mechanism highlights its role in the inhibition of bacterial growth through interference with their metabolic processes. In research contexts, sulfacetamide sodium salt is utilized to explore bacterial resistance mechanisms to sulfonamides, offering insights into how bacteria modify their enzymatic pathways to evade such inhibitory effects. Additionally, it serves as a tool in studies aimed at understanding the broader metabolic pathways involved in bacterial folic acid synthesis and the potential impact of metabolic disruption on bacterial viability. These investigations are crucial for advancing knowledge in microbiology and biochemistry, particularly in the study of antibacterial resistance and the design of effective strategies to combat bacterial infections without relying on traditional antibacterial approaches.


Sulfacetamide sodium salt (CAS 6209-17-2) References

  1. Topical bactrim versus trimethoprim and sulfonamide against nocardia keratitis.  |  Lee, LH., et al. 2001. Cornea. 20: 179-82. PMID: 11248825
  2. Assay of sulfacetamide sodium ophthalmic solutions by high-pressure liquid chromatography.  |  Penner, MH. 1975. J Pharm Sci. 64: 1017-9. PMID: 1133718
  3. Investigation of radiosterilization and dosimetric features of sulfacetamide sodium.  |  Colak, S. and Korkmaz, M. 2004. J Pharm Biomed Anal. 36: 791-8. PMID: 15533672
  4. Monitoring of five sulfonamide antibacterial residues in milk by in-tube solid-phase microextraction coupled to high-performance liquid chromatography.  |  Wen, Y., et al. 2005. J Agric Food Chem. 53: 8468-73. PMID: 16248539
  5. Validation of a Stability-Indicating Spectrometric Method for the Determination of Sulfacetamide Sodium in Pure Form and Ophthalmic Preparations.  |  Ahmed, S., et al. 2017. J Pharm Bioallied Sci. 9: 126-134. PMID: 28717336
  6. Validated Chromatographic Methods for the Simultaneous Determination of Sulfacetamide Sodium and Prednisolone Acetate in their Ophthalmic Suspension.  |  El-Ragehy, NA., et al. 2017. J Chromatogr Sci. 55: 1000-1005. PMID: 28985412
  7. Spectrophotometric analysis of binary mixtures of sulfonamides.  |  Wahbi, AA., et al. 1979. J Assoc Off Anal Chem. 62: 67-70. PMID: 422506
  8. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension.  |  Johansen, S., et al. 1996. Acta Ophthalmol Scand. 74: 259-64. PMID: 8828723
  9. Hydrate transformation of sodium sulfacetamide and neomycin sulphate  |  Nugrahani, I. L. M. A. and Min, S. S. 2015. Int. J. Pharm. Pharm. Sci. 7(10): 409-415.
  10. Development and validation of RP-HPLC method for simultaneous quantification of sulfacetamide sodium and prednisolone sodium phosphate  |  Abdullah, N., et al. 2019. Acta Poloniae Pharmaceutica-Drug Research. 76(1): 37-47.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Sulfacetamide sodium salt, 100 g

sc-264327
100 g
$54.00